Metaphysical presuppositions and scientific practices: Reductionism and organicism in cancer research

International Studies in the Philosophy of Science

Volumn 19, Issue 1, 2005, Pages 31-45

  Marcum, James A ^a  

^a BAYLOR UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33645213254     PISSN: 02698595     EISSN: 14699281     Source Type: Journal    
DOI: 10.1080/02698590500051076     Document Type: Article

References (48)

1. Barcellos-Hoff, M.H., J. Aggeler, T.J. Ram and M.J. Bissell. 1989. Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. Development 105: 223-35
2. Bissell, M.J. 1990. Mammary gland as a model for studies of gene expression in normal and malignant cells. Progressin Clinical and Biological Research 354A: 313-16
3. Bissell, M.J. and J. Aggeler. 1987. Dynamic reciprocity: how do extracellular matrix and hormones direct gene expression? Progress in Clinical and Biological Research 249: 251-62
4. Bissell, M.J. and M.H. Barcellos-Hoff. 1987. The influence of extracellular matrix on gene expression: is structure the message? Journal of Cell Science 8 (Suppl.): 327-43
5. Bissell, M.J., H.G. Hall and G. Parry. 1982. How does the extracellular matrix direct gene expression? Journal of Theoretical Biology 99: 31-68
6. Bissell, M.J., D.C. Radisky, A. Rizki, V.M. Weaver and O.W. Petersen. 2002. The organizing principle: microenvironmental influences in the normal and malignant breast. Differentiation 70: 537-46
7. Bodnar, A.G., M. Ouellette, M. Frolkis, S.E. Holt, C.P. Chiu, G.B. Morin, C.B. Harley, J.W. Shay, S. Lichtsteiner and W.E. Wright. 1998. Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349-52
8. Boveri, T. 1914. Zur Frage der Entstehung Maligner Tumoren. Jena: Fischer
9. Brown, Jr., G.E. 1994. The freedom and the responsibility of investigator-initiated research. Academic Medicine 69: 437-40
10. Burtt, E.A. 1932 [1924]. The Metaphysical Foundations of Modern Physical Science: A Historical and Critical Essay, rev. ed. New York: Harcourt, Brace
11. Collingwood, R.G. 1998 [1940]. An Essay on Metaphysics, rev. ed. Oxford: Clarendon Press
12. Duesberg, P.H. 1980. Transforming genes of retroviruses. Cold Spring Harbor Symposium on Quantitative Biology 44: 13-29
13. Feldman, S.D. and A.I. Tauber. 1997. Sickle cell anemia: reexamining the first 'molecular disease'. Bulletin of the History of Medicine 71: 623-50
14. Gilbert, S.F. and S. Sarkar. 2000. Embracing complexity: organicism in the 21st century. Developmental Dynamics 219: 1-9
15. Godfrey-Smith, P. 2000. Explanatory symmetries, preformation, and developmental systems theory. Philosophy of Science (Proceedings) 67: S322-31
16. Hahn, W.C., C.M. Counter, A.S. Lundberg, R.L. Beijersbergen, M.W. Brooks and R.A. Weinberg. 1999. Creation of human tumour cells with defined genetic elements. Nature 400: 464-8
17. Hanahan, D. and R.A. Weinberg. 2000. The hallmarks of cancer. Cell, 100: 57-70
18. Harris, H. 1986. The genetic analysis of malignancy. Journal of Cell Science 4 (Suppl.): 431-44
19. Jacks, T. and R.A. Weinberg. 2002. Taking the study of cancer cell survival to new dimension. Cell 111: 923-25
20. Kim, J.A. 2003. Targeted therapies for the treatment of cancer. American Journal of Surgery 186: 264-8
21. Kuhn, T.S. 1996 [1962]. The Structure of Scientific Revolutions, 3rd ed. Chicago, IL: University of Chicago Press
22. Land, H., L.F. Parada and R.A. Weinberg. 1983. Cellular oncogenes and multistep carcinogenesis. Science 222: 771-8
23. Lemonick, M.D. 1999. Cancer made to order. Time 154: 60
24. Marcum, J.A. and G.M.N. Verschuuren. 1986. Hemostatic regulation and Whitehead's philosophy of organism. Acta Biotheoretica, 35: 123-33
25. Oyama, S. 1985. The Ontogeny of Information. Cambridge: Cambridge University Press
26. Oyama, S., P.E. Griffths and R.D. Gray. 2001. Introduction: What is developmental systems theory?, in Cycles of Contingency: Developmental Systems and Evolution, edited by S. Oyama, P.E. Griffths and R.D. Gray. Cambridge, MA: MIT Press, 1-11
27. Petersen, O.W., L. Ronnov-Jessen, A.R. Howlett and M.J. Bissell. 1992. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proceedings of the National Academy of Sciences of the United States of America 89: 9064-8
28. Pickering, A. 1995. The Mangle of Practice: Time, Agency, and Science. Chicago, IL: University of Chicago Press
29. Proctor, R. 1995. Cancer Wars: How Politics Shapes What We Know and Don't Know about Cancer. New York: Basic Books
30. Rassoulzadegan, M., A. Cowie, A. Carr, N. Glaichenhaus, R. Kamen and F. Cuzin. 1982. The roles of individual polyoma virus early proteins in oncogenic transformation. Nature 300: 713-18
31. Reddy, E.P., R.K. Reynolds, E. Santos and M. Barbacid. 1982. A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature 300: 149-52
32. Root-Bernstein, R.S. 1999. Complementarity and contradiction in cancer research: the role of hierarchies in carcinogenesis. Anticancer Research 19: 4915-18
33. Shih, C., B.-Z. Shilo, M.P. Goldfarb, A. Dannenberg and R.A. Weinberg. 1979. Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin. Proceedings of the National Academy of Sciences of the United States of America 76: 5714-18
34. Sonnenschein, C. and A.M. Soto. 1999. The Society of Cells: Cancer and Control of Cell Proliferation. New York: Springer-Verlag
35. Sonnenschein, C. and A.M. Soto. 2000. Somatic mutation theory of carcinogenesis: why it should be dropped and replaced. Molecular Carcinogenesis 29: 205-11
36. Sterelny, K. and P.E. Griffths. 1999. Sex and Death: An Introduction to Philosophy of Biology. Chicago, IL: University of Chicago Press
37. Stevenson, M. and D.J. Volsky. 1986. Activated v-myc and v-ras oncogenes do not transform normal human lymphocytes. Molecular and Cellular Biology, 6: 3410-17
38. Tabin, C.J., S.M. Bradley, C.I. Bargmann, R.A. Weinberg, A.G. Papageorge, E.M. Scolnick, R. Dhar, D.R. Lowy, and E.H. Chang. 1982. Mechanism of activation of a human oncogene. Nature 300: 143-9
39. Van De Vijver, G., L. Van Speybroeck and W. Vandevyvere. 2003. Reflecting on complexity of biological systems: Kant and beyond? Acta Biotheoretica, 51: 101-40
40. Varmus, H. and R.A. Weinberg. 1993. Genes and the Biology of Cancer. New York: W.H. Freeman
41. Wang, F., V.M. Weaver, O.W. Petersen, C.A. Larabell, S. Dedhar, P. Briand, R. Lupu and M.J. Bissell. 1998. Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proceedings of the National Academy of Sciences of the United States of America 95: 14821-6
42. Weaver, V.M., O.W. Petersen, F. Wang, C.A. Larabell, P. Briand, C. Damsky and M.J. Bissell. 1997. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. Journal of Cell Biology 137: 231-45
43. Weinberg, R.A. 1983. Oncogenes and the molecular biology of cancer. Journal of Cell Biology 97: 1661-2
44. Weinberg. 1988a. The genetic origins of human cancer. Cancer 61: 1963-8
45. Weinberg. 1988b. Finding the anti-oncogene. Scientific American 259 (3): 44-51
46. Weinberg. 1994. You can't get there from here: the tortuous road to basic research. Academic Medicine 69: 441-4
47. Weinberg. 1996. The molecular basis of carcinogenesis: understanding the cell cycle clock. Cytokines and Molecular Therapy 2: 105-10
48. Weinberg. 1998. One Renegade Cell: How Cancer Begins. New York: Basic Books